Respiratory drug delivery is specially used to treat the diseases of lung and nose. This type of drug delivery offers complete non-invasive or painless approach to the topical active medications or the systemic drugs. Lung and the nose are mostly the targeted organs of the delivery of drugs that offer the opportunity for aerosol delivery of drug. This is majorly done through deposition on the right surface. Nonetheless, clearance ad filter mechanisms of the candidate’s body must be overcome for achieving successful applications. The much required size of particles majorly stimulates the technological methods for the production of aerosol through different inhalers. These include the nebulizers, pressurized metered dose inhalers, dry powder inhalers, and the non-pressurized liquid inhalers.
Respiratory Drug Delivery Market accounted for over US$ 39 billion in 2019. It is anticipated to grow at a CAGR of approximately 6.8% from 2020 to 2030.
Respiratory drug delivery offers treatment for diseases of the respiratory tract through noninvasive means to deliver either topically active medications or systemic drugs to target organs. The nose and lung are the target organs for the deposition of the aerosol drug. In asthma, drug delivery to the upper airways is needed while for alveolar lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, it is important to have drug deposition deep within the lungs rather than just the upper airways.
Major Key Players of the Respiratory Drug Delivery Market are:
3M, GlaxoSmithKline plc., AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH., Philips Respironics, Merck & Co., Inc., OMRON Healthcare, Cipla Inc., and others.
Download PDF to Know the Impact of COVID-19 on “Respiratory Drug Delivery Market” at: https://www.marketindustryreports.com/pdf/288
The market growth of respiratory drug delivery can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are suffering from asthma and 14.8 million adults have been diagnosed with COPD. Also, according to the WHO, smoking is considered to be a primary cause for COPD and more than 1 billion people inhale outdoor polluted air exposed to tobacco. These factors are leading to an upsurge in market growth.
The Respiratory Drug Delivery Market is segmented on the basis of product Formulation, Applications, Device Type, and region.
Major Formulation of Respiratory Drug Delivery Market covered are:
- Suspension Aerosols
- Solution Aerosols
- Dry Powder Formulations
Major Device Types of Respiratory Drug Delivery Market covered are:
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
Major Applications ofRespiratory Drug Delivery Market covered are:
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
– To study and analyze the global Respiratory Drug Delivery consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Respiratory Drug Delivery market by identifying its various sub-segments.
– Focuses on the key global Respiratory Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Respiratory Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Respiratory Drug Delivery Market Size
2.2 Respiratory Drug Delivery Growth Trends by Regions
2.3 Industry Trends
3 Market Share by Key Players
3.1 Respiratory Drug Delivery Market Size by Manufacturers
3.2 Respiratory Drug Delivery Key Players Head office and Area Served
3.3 Key Players Respiratory Drug Delivery Product/Solution/Service
3.4 Date of Enter into Respiratory Drug Delivery Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Respiratory Drug Delivery Sales by Product
4.2 Global Respiratory Drug Delivery Revenue by Product
4.3 Respiratory Drug Delivery Price by Product
5 Breakdown Data by End User
5.2 Global Respiratory Drug Delivery Breakdown Data by End User
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/288
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, mega trends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Phone: + 91 8956767535